Canopy Partners, LLC Novartis Ag Transaction History
Canopy Partners, LLC
- $299 Billion
- Q3 2025
A detailed history of Canopy Partners, LLC transactions in Novartis Ag stock. As of the latest transaction made, Canopy Partners, LLC holds 3,353 shares of NVS stock, worth $441,087. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,353
Previous 3,123
7.36%
Holding current value
$441,087
Previous $378 Million
13.78%
% of portfolio
0.14%
Previous 0.14%
Shares
7 transactions
Others Institutions Holding NVS
# of Institutions
1,599Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...